SSEA-4 Antibodies

Santa Cruz Biotechnology offers a broad range of SSEA-4 monoclonal antibodies for advanced research in stem cell biology and developmental studies. SSEA-4 monoclonal antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). SSEA-4, or Stage-Specific Embryonic Antigen 4, is a glycosphingolipid that plays a critical role in the identification and characterization of pluripotent stem cells. SSEA-4 is essential for understanding cell differentiation and has implications in regenerative medicine and cancer research. The presence of SSEA-4 serves as a marker for undifferentiated embryonic stem cells, supporting research in stem cell properties and behaviors. SSEA-4 expression patterns help scientists track cellular development stages and understand differentiation processes. Monitoring SSEA-4 levels enables researchers to assess stem cell maintenance and differentiation status in various experimental conditions. SSEA-4 monoclonal antibodies from Santa Cruz Biotechnology empower researchers worldwide to advance stem cell research and contribute to potential therapeutic breakthroughs.